What can both public and private sector stakeholders learn from current trends to accelerate innovation around the COVID-19 pandemic and other emerging global health threats, including antimicrobial resistance?
Nicholas Diamond and Kate Beale
Advertisement
Nicholas J. Diamond is a director for C&M International. Kate Beale is a senior policy director in Crowell & Moring's Government Affairs Group and affiliated with C&M International.
Articles by Nicholas Diamond and Kate Beale
Advertisement
Latest Updated Articles
- Advancing Health Innovation in 2022: Where Should We Focus?
Published: August 4th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
2
What Impact will DTC Programs have on Generic Drug Prices?
3
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
4
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
5
